Real Heart (HEART) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.026x

Based on the latest financial reports, Real Heart (HEART) has a cash flow conversion efficiency ratio of -0.026x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-1.94 Million ≈ $-208.80K USD) by net assets (Skr74.35 Million ≈ $8.00 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Real Heart defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Real Heart - Cash Flow Conversion Efficiency Trend (2014–2024)

This chart illustrates how Real Heart's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Real Heart Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Real Heart ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Garovaglio y Zorraquin S.A. BA:GARO	-0.041x
Property Perfect Public Company Limited BK:PF	0.009x
Grand Pacific Petrochemical Corp Pref TW:1312A	-0.026x
Park & Bellheimer AG F:PKB	0.143x
Vizione Holdings Bhd KLSE:7070	-0.027x
SeaStar Medical Holding Corporation NASDAQ:ICU	-0.393x
Gaxos.ai Inc NASDAQ:GXAI	-0.163x
Mustera Property Group Ltd AU:MPX	0.201x

Annual Cash Flow Conversion Efficiency for Real Heart (2014–2024)

The table below shows the annual cash flow conversion efficiency of Real Heart from 2014 to 2024. For the full company profile with market capitalisation and key ratios, see HEART company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Skr67.34 Million ≈ $7.25 Million	Skr-12.99 Million ≈ $-1.40 Million	-0.193x	+36.81%
2023-12-31	Skr82.04 Million ≈ $8.83 Million	Skr-25.05 Million ≈ $-2.70 Million	-0.305x	-304.00%
2022-12-31	Skr97.65 Million ≈ $10.51 Million	Skr-7.38 Million ≈ $-794.22K	-0.076x	+12.86%
2021-12-31	Skr111.29 Million ≈ $11.98 Million	Skr-9.65 Million ≈ $-1.04 Million	-0.087x	+33.92%
2020-12-31	Skr71.69 Million ≈ $7.72 Million	Skr-9.41 Million ≈ $-1.01 Million	-0.131x	-5.77%
2019-12-31	Skr59.00 Million ≈ $6.35 Million	Skr-7.32 Million ≈ $-788.00K	-0.124x	+62.85%
2018-12-31	Skr19.30 Million ≈ $2.08 Million	Skr-6.45 Million ≈ $-693.86K	-0.334x	+6.75%
2017-12-31	Skr27.52 Million ≈ $2.96 Million	Skr-9.86 Million ≈ $-1.06 Million	-0.358x	-66.32%
2016-12-31	Skr16.20 Million ≈ $1.74 Million	Skr-3.49 Million ≈ $-375.55K	-0.215x	+8.16%
2015-12-31	Skr5.97 Million ≈ $642.14K	Skr-1.40 Million ≈ $-150.60K	-0.235x	+0.45%
2014-12-31	Skr7.50 Million ≈ $806.85K	Skr-1.77 Million ≈ $-190.08K	-0.236x	--

About Real Heart

ST:HEART Sweden Medical Devices

Market Cap

$12.48 Million

Skr115.97 Million SEK

Market Cap Rank

#26485 Global

#570 in Sweden

Share Price

Skr23.20

Change (1 day)

+1.75%

52-Week Range

Skr13.00 - Skr29.00

All Time High

Skr1625.78